Cargando…

Urinary Incontinence and Overactive Bladder Symptoms in Women with Breast Cancer Being Treated with Oral Hormone Therapy

Objective The objective of the present study is to observe the frequency and severity of urinary symptoms in women with breast cancer (BC) being treated with oral hormone therapy, associating them to drug adherence. Methods The participants were interviewed once from June to October 2016. The eval...

Descripción completa

Detalles Bibliográficos
Autores principales:	Stahlschmidt, Rebeca, Ferracini, Amanda Canato, Medeiros, Luana Moreira de, Souza, Cinthia Madeira de, Juliato, Cassia Raquel Teatin, Mazzola, Priscila Gava
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Thieme Revinter Publicações Ltda. 2020
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10309229/ https://www.ncbi.nlm.nih.gov/pubmed/33254267 http://dx.doi.org/10.1055/s-0040-1718440

Ejemplares similares

Switching of Hormone Therapies in Breast Cancer Women
por: Medeiros, Luana Moreira de, et al.
Publicado: (2021)

Self-Medication Among Pregnant Women: Prevalence and Associated Factors
por: Pereira, Gabriela, et al.
Publicado: (2021)

Corrigendum: Self-Medication Among Pregnant Women: Prevalence and Associated Factors
por: Pereira, Gabriela, et al.
Publicado: (2021)

Is There Any Difference Between Depression and Anxiety in Overactive Bladder According to Sex? A Systematic Review and Meta-Analysis
por: Melotti, Iane Glauce R, et al.
Publicado: (2017)

Potential Drug Interactions and Drug Risk during Pregnancy and Breastfeeding: An Observational Study in a Women's Health Intensive Care Unit
por: Ferracini, Amanda Canato, et al.
Publicado: (2017)

Impact of Vaginal Delivery on Pelvic Floor
por: Juliato, Cássia Raquel Teatin
Publicado: (2020)

Analysis of information received during treatment and adherence to tamoxifen in breast cancer patients
por: Cruz, Aline, et al.
Publicado: (2017)

Fesoterodine for the treatment of urinary incontinence and overactive bladder
por: Ellsworth, Pamela
Publicado: (2009)

Provision and Guidance for Postpartum Contraception - Ensuring Reproductive Rights during Times of Crises
por: Barbieri, Mariane Massaini, et al.
Publicado: (2021)

Socioeconomic Costs of Overactive Bladder and Stress Urinary Incontinence in Korea
por: Sung, Wooseuk, et al.
Publicado: (2012)

Impact of smoking habit on overactive bladder symptoms and incontinence in women
por: Kawahara, Takashi, et al.
Publicado: (2020)

Comparison between two methods of the immediate post-placental insertion of copper intrauterine device in vaginal birth—a protocol for a randomized clinical trial
por: Herculano, Thuany Bento, et al.
Publicado: (2022)

Clinical relevancy and risks of potential drug–drug interactions in intensive therapy
por: Rodrigues, Aline Teotonio, et al.
Publicado: (2015)

Validation of a bladder symptom screening tool in women with incontinence due to overactive bladder
por: Cardozo, Linda, et al.
Publicado: (2014)

Female Functional Constipation Is Associated with Overactive Bladder Symptoms and Urinary Incontinence
por: Maeda, Takahiro, et al.
Publicado: (2017)

Postplacental Placement of Intrauterine Devices: Acceptability, Reasons for Refusal and Proposals to Increase its Use
por: Kraft, Maria Beatriz de Paula Leite, et al.
Publicado: (2021)

Understanding overactive bladder and urgency incontinence: what does the brain have to do with it?
por: Smith, Ariana L.
Publicado: (2018)

The effect of vitamin D deficiency in children with overactive bladder related urinary incontinence
por: Özçift, Burak, et al.
Publicado: (2022)

Toileting behaviors, urinary cues, overactive bladder, and urinary incontinence in older women
por: O’Connell, Kathleen A., et al.
Publicado: (2022)

Health Resource Utilization and Cost for Patients with Incontinent Overactive Bladder Treated with Anticholinergics
por: Yehoshua, Alon, et al.
Publicado: (2016)

Mid- to Long-Term Magnetic Resonance Imaging Results of Two Prolapse Surgeries for Apical Defect: A Secondary Analysis of a Randomized Controlled Trial
por: Santos Junior, Luiz Carlos, et al.
Publicado: (2021)

GSTP1 and ABCB1 Polymorphisms Predicting Toxicities and Clinical Management on Carboplatin and Paclitaxel‐Based Chemotherapy in Ovarian Cancer
por: Ferracini, Amanda Canato, et al.
Publicado: (2020)

The relationship between depression and overactive bladder/urinary incontinence symptoms in the clinical OAB population
por: Lai, H. Henry, et al.
Publicado: (2016)

Experience of a Tertiary Service in the Treatment of Women with Cervical Pregnancy
por: Mori, Karen Hiromi, et al.
Publicado: (2022)

Adverse Drug Reactions and quality deviations monitored by spontaneous reports
por: Visacri, Marília Berlofa, et al.
Publicado: (2015)

Practical aspects of lifestyle modifications and behavioural interventions in the treatment of overactive bladder and urgency urinary incontinence
por: Wyman, J F, et al.
Publicado: (2009)

Impact of mirabegron extended-release on the treatment of overactive bladder with urge urinary incontinence, urgency, and frequency
por: Lee, Raymond T, et al.
Publicado: (2013)

The Changes of Voiding Pattern After Midurethral Sling Between Pure Stress Urinary Incontinence and Stress Urinary Incontinence With Overactive Bladder Group
por: Kim, Sun Wook, et al.
Publicado: (2014)

Overactive bladder
por: Wallace, Karen M., et al.
Publicado: (2015)

Correlations among improvements in urgency urinary incontinence, health-related quality of life, and perception of bladder-related problems in incontinent subjects with overactive bladder treated with tolterodine or placebo
por: Van Kerrebroeck, Philip EV, et al.
Publicado: (2009)

Can the Pessary Use Modify the Vaginal Microbiological Flora? A Cross-sectional Study
por: Coelho, Suelene Costa de Albuquerque, et al.
Publicado: (2017)

Impact of Transobturator Tape Treatment on Overactive Bladder Symptoms, Particularly Nocturia, in Patients With Mixed Urinary Incontinence
por: Lee, Sang Keun, et al.
Publicado: (2014)

Cardiovascular safety in refractory incontinent patients with overactive bladder receiving add‐on mirabegron therapy to solifenacin (BESIDE)
por: Drake, Marcus J., et al.
Publicado: (2017)

Sexual Disorders in Women with Overactive Bladder and Urinary Stress Incontinence Compared to Controls: A Prospective Study
por: Naumann, Gert, et al.
Publicado: (2021)

OnabotulinumtoxinA 100U provides significant improvements in overactive bladder symptoms in patients with urinary incontinence regardless of the number of anticholinergic therapies used or reason for inadequate management of overactive bladder
por: Sievert, K-D, et al.
Publicado: (2014)

Postmenopausal overactive bladder
por: Tomaszewski, Jacek
Publicado: (2014)

Treatment success for overactive bladder with urinary urge incontinence refractory to oral antimuscarinics: a review of published evidence
por: Campbell, Jonathan D, et al.
Publicado: (2009)

Impact of overactive bladder on quality of life and resource use: results from Korean Burden of Incontinence Study (KOBIS)
por: Lee, Kyu Sung, et al.
Publicado: (2015)

Efficacy and tolerability of mirabegron in female patients with overactive bladder symptoms after surgical treatment for stress urinary incontinence
por: Özkidik, Mete, et al.
Publicado: (2019)

Urodynamic Detrusor Overactivity in Patients with Overactive Bladder Symptoms
por: Al-Ghazo, Mohammed A., et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_m0v6o1g1shgs8vv529f2u69k93